Neuro-oncology: Glioblastoma-community adjusts to new standard of care

Nature Reviews Neurology

Volumn 8, Issue 5, 2012, Pages 244-246

  Desjardins, Annick ^a   Friedman, Henry S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE;

CANCER ADJUVANT THERAPY; CHEMORADIOTHERAPY; GENE; GLIOBLASTOMA; HUMAN; MGMT GENE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; UNITED STATES;

BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; SOCIAL WELFARE; STANDARD OF CARE; UNITED STATES;

EID: 84860882908     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2012.42     Document Type: Review

References (10)

1. Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987-996 (2005). (Pubitemid 40349501)
2. Yabroff, K. R., Harlan, L., Zeruto, C., Abrams, J. & Mann, B. Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006. Neuro Oncol. 14, 351-359 (2012).
3. Lacroix, M. et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J. Neurosurg. 95, 190-198 (2001). (Pubitemid 32799739)
4. Sanai, N. & Berger, M. S. Glioma extent of resection and its impact on patient outcome. Neurosurgery 62, 753-766 (2008).
5. Hegi, M. E. et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352, 997-1003 (2005). (Pubitemid 40349502)
6. van den Bent, M. J., Hegi, M. E. & Stupp, R. Recent developments in the use of chemotherapy in brain tumours. Eur. J. Cancer 42, 582-588 (2006). (Pubitemid 43343679)
7. Grossman, S. A. et al. Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial. J. Clin. Oncol. 27, 4155-4161 (2009).
8. Motomura, K. et al. Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter study. Cancer 117, 1721-1730 (2011).
9. Butowski, N. et al. Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma. Neuro Oncol. 13, 1331-1338 (2011).
10. Gilbert, M. et al. RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM) [abstract]. J. Clin. Oncol. 29 (Suppl. 15), 2006 (2011).